Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vaxcyte Inc (NQ: PCVX ) 83.24 -0.93 (-1.10%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Vaxcyte Inc < Previous 1 2 3 Next > US Stocks Mixed; Dow Jumps 200 Points October 24, 2022 U.S. stocks traded mixed this morning, with the Dow Jones surging around 200 points on Monday. Via Benzinga Vaxcyte Shares Are Soaring: Here's Why October 24, 2022 Vaxcyte Inc (NASDAQ: PCVX) shares are trading higher Monday after the company announced positive topline results from the Phase 1/2 clinical proof-of-concept study evaluating the safety, tolerability... Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session October 24, 2022 Gainers Applied Genetic Techs (NASDAQ:AGTC) shares moved upwards by 62.0% to $0.39 during Monday's pre-market session. The company's market cap stands at $26.3 million. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday October 24, 2022 Good morning, traders! We're starting off the week with a breakdown of the biggest pre-market stock movers for Monday morning! Via InvestorPlace Earnings Scheduled For February 28, 2022 February 28, 2022 Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (... Via Benzinga Vaxcyte Completes Enrolment In Mid-Stage Pneumococcal Disease Study, Sees Top-line Data In H1 2013 September 06, 2022 Vaxcyte (NASDAQ: PCVX) has completed patient enrollment in the Phase 2 study evaluating VAX-24 in healthy adults 65 years of age and older. VAX-24 is its lead, 24-valent pneumococcal conjugate vaccine... Via Benzinga Recap Of Thursday's Biotech Catalysts - End Of the Day Summary August 04, 2022 The European Commission (EC) has approved AstraZeneca (NASDAQ: AZN) and Merck’s (NYSE: MRK) LYNPARZA as monotherapy or in combination with endocrine therapy for the adjuvant treatment of adult patients... Via Benzinga Vaxcyte Concludes Enrolment In Mid-Stage Pneumococcal Disease Study July 12, 2022 Vaxcyte (NASDAQ: PCVX) completed patient enrollment in the Phase 2 portion of the ongoing Phase 1/2 proof-of-concept study evaluating VAX-24 in healthy adults 50 to 64 years of age. Via Benzinga 48 Biggest Movers From Yesterday January 14, 2022 Gainers Singularity Future Technology Ltd. (NASDAQ: SGLY) shares rose 25.9% to settle at $5.01 on Thursday. MedAvail Holdings, Inc (NASDAQ: MDVL) gained 24.4% to settle at $1.58... Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session January 13, 2022 Gainers Stealth BioTherapeutics (NASDAQ:MITO Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session January 13, 2022 Gainers Rockwell Medical (NASDAQ:RMTI) st... Via Benzinga 26 Stocks Moving In Thursday's Mid-Day Session January 13, 2022 Gainers Dave Inc. (NASDAQ: DAVE) gained 29.4% to $6.73. Takung Art Co., Ltd. (NASDAQ: TKAT) shares gained 18.6% to $4.1499. Traders are circulating earlier news that China is... Via Benzinga The Daily Biotech Pulse: Adagio's Antibody Effective Against Omicron, Sarepta Terminates Gene Therapy Deal, AstraZeneca Inks Oncology Pact January 13, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Says Lead Monoclonal Antibody Effective Against Omicron Variant Adagio... Via Benzinga Vaxcyte Raises $100M Via Equity To Fund Development Of Lead Pneumococcal Vaccine Candidate January 13, 2022 Vaxcyte Inc (NASDAQ: PCVX) priced its previously announced offering of common stock and pre-funded warrants at $20.00 per share, and $19.999 per underlying share,... Via Benzinga 20 Stocks Moving in Thursday's Pre-Market Session January 13, 2022 Gainers BTCS Inc. (NASDAQ: BTCS) rose 41% to $9.45 in pre-market trading after jumping 19% on Wednesday. Adagio Therapeutics, Inc. (NASDAQ: ADGI) rose 22.8% to $7.16 in pre-... Via Benzinga A Peek Into The Markets: US Stock Futures Mostly Flat Ahead Of PPI, Jobless Claims January 13, 2022 Pre-open movers U.S. stock futures traded mostly flat in early pre-market trade after closing slightly higher in the previous session. Investors are awaiting earnings results from... Via Benzinga 5 Stocks To Watch For January 13, 2022 January 13, 2022 Some of the stocks that may grab investor focus today are: Wall Street expects Delta Air Lines, Inc. (NYSE: DAL) to report quarterly earnings at $0.13 per share on revenue of $... Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session January 12, 2022 Gainers Biomerica (NASDAQ:BMRA) stock inc... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session December 29, 2021 Gainers Biofrontera (NASDAQ: Via Benzinga Wingstop, Akamai Initiations Among Today's Top Calls On Wall Street December 29, 2021 Benchmark analyst Todd Brooks initiated coverage of Wingstop (WING) with a Hold rating and no price target. The analyst believes the stock's risk/reward is balanced at these levels given the current Via Talk Markets 46 Biggest Movers From Yesterday August 19, 2021 Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares climbed 189.5% to close at $9.90 on Wednesday after surging over 15% on Tuesday. SGOCO Group, Ltd. (NASDAQ: SGOC) surged 67... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session August 18, 2021 Gainers PharmaCyte Biotech (NASDAQ:PMCB) shares rose 119.0% to $7.49 during Wednesday's regular session. Trading volume for PharmaCyte Biotech's stock is 144.3... Via Benzinga 34 Stocks Moving In Wednesday's Mid-Day Session August 18, 2021 Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 139% to $8.18 after surging over 15% on Tuesday. Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 58% to $... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session June 24, 2021 Gainers Pieris Pharmaceuticals (NASDAQ:PIRS) stock moved upwards by 27.11% to $4.5 during Thursday's regular session. As of 12:30 EST, this security is trading at a... Via Benzinga The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron May 12, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... Via Benzinga Exposures COVID-19 Stocks That Hit 52-Week Lows On Tuesday May 11, 2021 Before 10 a.m. ET Tuesday, 173 stocks hit new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Snowflake (NYSE:SNOW... Via Benzinga The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings May 11, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -... Via Benzinga Exposures COVID-19 Product Safety The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs May 07, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... Via Benzinga The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs April 22, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) Alexion Pharmaceuticals,... Via Benzinga Stocks That Hit 52-Week Lows On Wednesday April 21, 2021 Wednesday morning, 25 companies reached new 52-week lows. Intriguing Points: Lufax Holding (NYSE:LU) was the biggest company by market cap to set a new 52-week low... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.